AOA addresses Eyebot technology

Published on November 3, 2025
The AOA Federal Relations and Advocacy Action Committee and the New Technology Committee advocate for patient safety and greater regulation of potentially misleading diagnostic devices.
Continue reading on website
Other news

Capillary Nonperfusion in DR A Poor Predictor of Functional Loss

November 3, 2025
Retinal capillary nonperfusion plays a decisive role in diabetic retinopathy’s (DR) pathogenesis. However, this development may not be evident unless it is revealed by fundus fluorescein angiography (FA) or OCT angiography (OCT-A). To date, there is no therapy to prevent its occurrence or to revert it (i.e., achieve revascularization). 

Managing Cataract and Glaucoma Patients by Combining MIGS and Sustained Drug Delivery to Improve Quality of Life | Optometry Times - Clinical News

November 3, 2025